Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Patients with persistent disability and those who desired surgical intervention underwent decompression surgery
Haro C, Villena J, Zelaya H, Alvarez S, Agero G
New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions Issues like pancreatitis, stomach paralysis higher among patients using GLP-1 inhibitor medications Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday
PMID: 30971965
US$ 20.99
US$ 23.42
US$ 25.52
US$ 26.09
US$ 25.80
